Clinical trials
Enrolling by invitation Diabetes Mellitus, Type 2 trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 8 |
| 2025 | 12 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kaiser Permanente | 3 |
| University of Colorado, Denver | 2 |
| Vanderbilt University Medical Center | 2 |
| Baylor Research Institute | 1 |
| Chang Gung Memorial Hospital | 1 |
| Columbia University | 1 |
| Endogenex, Inc. | 1 |
| Fanfan Zheng | 1 |
| Federico II University | 1 |
| Gazi University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 43 |
| Hypertension | 5 |
| Diabetes Mellitus | 4 |
| Cardiovascular Diseases | 3 |
| Glucose Intolerance | 3 |
| Obesity | 3 |
| Overweight | 3 |
| Diabetes, Gestational | 2 |
| Dyslipidemias | 2 |
| Insulin Resistance | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.